Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory

I Plastira1, E Bernhart1, M Goeritzer1,2

  • 1Institute of Molecular Biology and Biochemistry, Medical University of Graz, Neue Stiftingtalstrasse 6/6, 8010, Graz, Austria.

Abstract

Insights

Lysophosphatidic acid (LPA) drives microglial cells to become inflammatory and migratory via LPAR5 and protein kinase D (PKD) signaling. Inhibiting this pathway reduces neuroinflammation and microglial cytotoxicity.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Extracellular lysophosphatidic acid (LPA) signals through G protein-coupled receptors (LPAR1-6), crucial for nervous system development.
  • Elevated LPA levels during neuroinflammation or brain damage can impair brain function.
  • This study focuses on 1-oleyl-2-hydroxy-sn-glycero-3-phosphate (LPA) and its role in microglial activation via LPAR5 and protein kinase D (PKD).

Purpose of the Study:

  • To investigate the role of LPA in microglial cell migration and phenotype.
  • To elucidate the signaling pathways involved, specifically LPAR5 and PKD.
  • To explore potential therapeutic targets for neuroinflammation associated with increased LPA.

Main Methods:

  • Utilized xCELLigence system and time-lapse microscopy to assess microglial migration.
  • Analyzed M1/M2 markers using confocal microscopy, flow cytometry, and immunoblotting.
  • Quantified gene expression, cytokine secretion, transcription factor activity, reactive oxygen species (ROS), nitric oxide (NO) production, phagocytosis, and cytotoxicity.

Main Results:

  • LPA activated MAPK and AKT signaling, promoting pro-inflammatory transcription factors (NF-κB, c-Jun, STAT1, STAT3).
  • LPA enhanced microglial migration, M1 marker expression, pro-inflammatory cytokine/chemokine secretion, ROS/NO production, and neuronal cytotoxicity.
  • Inhibition of LPAR5 or PKD pathways abrogated LPA-induced pro-inflammatory responses and microglial cytotoxicity.

Conclusions:

  • Inflammatory LPA levels promote microglial migration and a pro-inflammatory phenotype through the LPAR5/PKD signaling axis.
  • Interfering with the LPAR5/PKD pathway effectively reduces microglial migration and cytotoxicity.
  • Targeting this axis offers a potential therapeutic strategy for neuroinflammatory conditions with elevated LPA.

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.0K
Mechanism of Lamellipodia Formation01:31

Mechanism of Lamellipodia Formation

Cells migrating in response to external stimuli form lamellipodia, which are thin membrane protrusions supported by a mesh of linked, branched, or unbranched actin filaments. These actin filaments interact with myosin motor proteins, creating the dynamic actomyosin complex within the cytoskeleton. Contractility, or the ability to generate contractile stress, is inherent to the actomyosin complex. It helps cells detect the stiffness of the surrounding ECM and exert contractile force for...
3.8K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.3K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
8.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K